Associations between the gut microbiome and colorectal cancer (CRC) have been uncovered, but larger and more diverse studies are needed to assess their potential clinical use. We expanded upon 12 metagenomic datasets of patients with CRC (n = 930), adenomas (n = 210) and healthy control individuals (n = 976; total n = 2,116) with 6 new cohorts (n = 1,625) providing granular information on cancer stage and the anatomic location of tumors. We improved CRC prediction accuracy based solely on gut metagenomics (average area under the curve = 0.85) and highlighted the contribution of 19 newly profiled species and distinct Fusobacterium nucleatum clades. Specific gut species distinguish left-sided versus right-sided CRC (area under the curve = 0.66) with an enrichment of oral-typical microbes. We identified strain-specific CRC signatures with the commensal Ruminococcus bicirculans and Faecalibacterium prausnitzii showing subclades associated with late-stage CRC. Our analysis confirms that the microbiome can be a clinical target for CRC screening and characterizes it as a biomarker for CRC progression.

Biomedical Center Faculty of Medicine in Pilsen Charles University Prague Czech Republic

Candiolo Cancer Institute FPO IRCCS Candiolo Italy

Center of Clinical Investigations for In Situ Biotherapies of Cancer INSERM CIC1428 Villejuif France

Clinical and Translational Epidemiology Unit Massachusetts General Hospital Boston MA USA

Department CIBIO University of Trento Trento Italy

Department of Biophysics School of Medicine Yeditepe University Istanbul Turkey

Department of Biostatistics Harvard T H Chan School of Public Health Boston MA USA

Department of Clinical and Biological Sciences University of Torino Torino Italy

Department of Colorectal Surgery Clinica S Rita Vercelli Italy

Department of Computer Science University of Torino Torino Italy

Department of Hepatogastroenterology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Medical Biology School of Medicine Yeditepe University Istanbul Turkey

Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czech Republic

Department of Surgery University Hospital and Faculty of Medicine in Pilsen Charles University Prague Czech Republic

Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa Pisa Italy

Departments of Epidemiology and Nutrition Harvard T H Chan School of Public Health Boston MA USA

Faculté de Médecine Université Paris Saclay Kremlin Bicêtre France

Graduate School of Natural and Applied Sciences Yeditepe University Istanbul Turkey

Gustave Roussy Villejuif France

Harvard Chan Microbiome in Public Health Center Harvard T H Chan School of Public Health Boston MA USA

IEO European Institute of Oncology IRCCS Milan Italy

Infectious Disease and Microbiome Program Broad Institute of MIT and Harvard Cambridge MA USA

Institut National de la Santé Et de la Recherche Médicale U1015 Equipe Labellisée Ligue Nationale contre le Cancer Villejuif France

Institute of Biology and Medical Genetics 1st Medical Faculty Charles University Prague Czech Republic

Italian Institute for Genomic Medicine c o IRCCS Candiolo Candiolo Italy

Masaryk Memorial Cancer Institute Brno Czech Republic

RECETOX Faculty of Science Masaryk University Brno Czech Republic

See more in PubMed

Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). PubMed DOI

Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233–254 (2023). PubMed DOI

Keum, N. & Giovannucci, E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 16, 713–732 (2019). PubMed DOI

Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72, 409–436 (2022). PubMed DOI

Huels, D. J. & Sansom, O. J. Stem vs non-stem cell origin of colorectal cancer. Br. J. Cancer 113, 1–5 (2015). PubMed DOI PMC

Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008). PubMed DOI PMC

Elinav, E. et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759–771 (2013). PubMed DOI

Schmitt, M. & Greten, F. R. The inflammatory pathogenesis of colorectal cancer. Nat. Rev. Immunol. 21, 653–667 (2021). PubMed DOI

Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022). PubMed DOI

Wilson, M. R. et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science 363, eaar7785 (2019). PubMed DOI PMC

Brennan, C. A. & Garrett, W. S. Fusobacterium nucleatum-symbiont, opportunist and oncobacterium. Nat. Rev. Microbiol. 17, 156–166 (2019). PubMed DOI PMC

Feng, Q. et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat. Commun. 6, 6528 (2015). PubMed DOI

Gupta, A. et al. Association of Flavonifractor plautii, a flavonoid-degrading bacterium, with the gut microbiome of colorectal cancer patients in India. mSystems 4, e00438-19 (2019). PubMed DOI PMC

Vogtmann, E. et al. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS ONE 11, e0155362 (2016). PubMed DOI PMC

Yachida, S. et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat. Med. 25, 968–976 (2019). PubMed DOI

Yu, J. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66, 70–78 (2017). PubMed DOI

Zeller, G. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014). PubMed DOI PMC

Thomas, A. M. et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat. Med. 25, 667–678 (2019). PubMed DOI PMC

Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679–689 (2019). PubMed DOI PMC

Young, C. et al. The colorectal cancer-associated faecal microbiome of developing countries resembles that of developed countries. Genome Med. 13, 27 (2021). PubMed DOI PMC

Zwinsová, B. et al. Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression. Cancers 13, 4799 (2021). PubMed DOI PMC

Dejea, C. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl Acad. Sci. USA 111, 18321–18326 (2014). PubMed DOI PMC

Zepeda-Rivera, M. et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 628, 424–432 (2024). PubMed DOI PMC

Everett, C. et al. Overview of the Microbiome Among Nurses study (Micro-N) as an example of prospective characterization of the microbiome within cohort studies. Nat. Protoc. 16, 2724–2731 (2021). PubMed DOI PMC

Blanco-Míguez, A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633–1644 (2023). PubMed DOI PMC

Pasolli, E. et al. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell 176, 649–662.e20 (2019). PubMed DOI PMC

Pasolli, E. et al. Accessible, curated metagenomic data through ExperimentHub. Nat. Methods 14, 1023–1024 (2017). PubMed DOI PMC

Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021). PubMed DOI PMC

Pasolli, E., Truong, D. T., Malik, F., Waldron, L. & Segata, N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput. Biol. 12, e1004977 (2016). PubMed DOI PMC

Asnicar, F. et al. Precise phylogenetic analysis of microbial isolates and genomes from metagenomes using PhyloPhlAn 3.0. Nat. Commun. 11, 2500 (2020). PubMed DOI PMC

Human Microbiome Project. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012). DOI

Nguyen, L. H. et al. Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men. Gastroenterology 158, 1313–1325 (2020). PubMed DOI

Zhang, Y. et al. Oleic acid and insulin as key characteristics of T2D promote colorectal cancer deterioration in xenograft mice revealed by functional metabolomics. Front. Oncol. 11, 685059 (2021). PubMed DOI PMC

Bell, H. N. et al. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metab. 35, 134–149.e6 (2023). PubMed DOI

GBD 2019 Colorectal Cancer Collaborators. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7, 627–647 (2022). DOI

Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. 27, 321–332 (2021). PubMed DOI PMC

Thompson, K. N. et al. Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes. Sci. Transl. Med. 15, eabn4722 (2023). PubMed DOI

Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662 (2019). PubMed DOI PMC

Mashima, I. & Nakazawa, F. The influence of oral Veillonella species on biofilms formed by Streptococcus species. Anaerobe 28, 54–61 (2014). PubMed DOI

Yusof, H. M., Ab-Rahim, S., Suddin, L. S., Saman, M. S. A. & Mazlan, M. Metabolomics profiling on different stages of colorectal cancer: a systematic review. Malays. J. Med. Sci. 25, 16–34 (2018). PubMed DOI PMC

Dougherty, M. W. & Jobin, C. Shining a light on colibactin biology. Toxins 13, 346 (2021). PubMed DOI PMC

Karcher, N. et al. Analysis of 1321 Eubacterium rectale genomes from metagenomes uncovers complex phylogeographic population structure and subspecies functional adaptations. Genome Biol. 21, 138 (2020). PubMed DOI PMC

Mukherjee, A., Lordan, C., Ross, R. P. & Cotter, P. D. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes 12, 1802866 (2020). PubMed DOI PMC

Wang, Y. et al. Eubacterium rectale contributes to colorectal cancer initiation via promoting colitis. Gut Pathog. 13, 2 (2021). PubMed DOI PMC

Ryu, S. W. et al. Gut microbiota Eubacterium callanderi exerts anti-colorectal cancer activity. Microbiol.Spectr. 10, e02531–22 (2022). PubMed DOI PMC

Belcheva, A. & Martin, A. Gut microbiota and colon cancer: the carbohydrate link. Mol. Cell Oncol. 2, e969630 (2015). PubMed DOI

Roelands, J. et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat. Med. 29, 1273–1286 (2023). PubMed DOI PMC

Zhao, L. et al. Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients. Oncogene 41, 4200–4210 (2022). PubMed DOI PMC

Xia, X. et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome 8, 108 (2020). PubMed DOI PMC

Bertolini, M. et al. Oral microorganisms and biofilms: new insights to defeat the main etiologic factor of oral diseases. Microorganisms 10, 2413 (2022). PubMed DOI PMC

Nguyen, L. H. et al. The sulfur microbial diet is associated with increased risk of early-onset colorectal cancer precursors. Gastroenterology 161, 1423–1432.e4 (2021). PubMed DOI

Yang, J. et al. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families. Gut Microbes 11, 918–929 (2020). PubMed DOI PMC

Yang, Y. et al. Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat. Commun. 12, 6757 (2021). PubMed DOI PMC

Liu, N.-N. et al. Multi-kingdom microbiota analyses identify bacterial–fungal interactions and biomarkers of colorectal cancer across cohorts. Nat. Microbiol. 7, 238–250 (2022). PubMed DOI PMC

Obón-Santacana, M. et al. Meta-analysis and validation of a colorectal cancer risk prediction model using deep sequenced fecal metagenomes. Cancers (Basel) 14, 4214 (2022). PubMed DOI

Amin, M. B. et al. (eds) in AJCC Cancer Staging Manual 8th edn, Ch. 10 (Springer, 2017).

Baran, B. et al. Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterol. Res. Pract. 11, 264–273 (2018). DOI

Pardini, B. et al. A fecal microRNA signature by small RNA sequencing accurately distinguishes colorectal cancers: results from a multicenter study. Gastroenterology 165, 582–599.e8 (2023). PubMed DOI

Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012). PubMed DOI PMC

Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014). PubMed DOI PMC

Benson, G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27, 573–580 (1999). PubMed DOI PMC

Brito, I. L. et al. Mobile genes in the human microbiome are structured from global to individual scales. Nature 535, 435–439 (2016). PubMed DOI PMC

Ferretti, P. et al. Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome. Cell Host Microbe 24, 133–145.e5 (2018). PubMed DOI PMC

Kartal, E. et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut 71, 1359–1372 (2022). PubMed DOI

Nagata, N. et al. Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology 163, 222–238 (2022). PubMed DOI

Hedges, L. V. Distribution theory for Glass’s estimator of effect size and related estimators. J. Educ. Stat. 6, 107–128 (1981). DOI

Hartung, J. & Knapp, G. On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat. Med. 20, 1771–1782 (2001). PubMed DOI

Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021). PubMed DOI PMC

Ghazi, A. R., et al. Quantifying metagenomic strain associations from microbiomes with Anpan. Preprint at bioRxiv https://doi.org/10.1101/2025.01.06.631550 (2025).

Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013). PubMed DOI

Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012). PubMed DOI

Forslund, S. K. et al. Combinatorial, additive and dose-dependent drug–microbiome associations. Nature 600, 500–505 (2021). PubMed DOI

Xu, Q. et al. Metagenomic and metabolomic remodeling in nonagenarians and centenarians and its association with genetic and socioeconomic factors. Nat. Aging 2, 438–452 (2022). PubMed DOI

Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822–828 (2014). PubMed DOI

He, Q. et al. Two distinct metacommunities characterize the gut microbiota in Crohn’s disease patients. Gigascience 6, gix050 (2017). DOI

iMSMS Consortium. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. Cell 185, 3467–3486.e16 (2022). DOI PMC

Zhang, X. et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21, 895–905 (2015). PubMed DOI

Nagy-Szakal, D. et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome 5, 44 (2017). PubMed DOI PMC

Zhou, C. et al. Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis. J. Autoimmun. 107, 102360 (2020). PubMed DOI

Xie, H. et al. Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome. Cell Syst. 3, 572–584.e3 (2016). PubMed DOI PMC

Piccinno, G. et al. Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer. Zenodo https://doi.org/10.5281/zenodo.15069068 (2025).